GIP has been shown to decrease food intake while blunting the metabolic adaptive responses that usually occur with calorie restriction resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids
Our products are intended for investigational use only and is not suitable for human or animal consumption
All trials employed randomized, double-blind, placebo-controlled designs, representing the gold standard for clinical research
Less body fat generally means a higher proportion of lean muscle mass, which can contribute to strength, speed, endurance, and agility
What are the functions of peptides